arrow
返回
R

Rami S. Komrokji

h. lee moffitt cancer center

68H指数
1.5K论文数
1.9W被引数
收录论文 202
发表时间
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)基于低甲基化制剂治疗的反应对高风险骨髓增生异常综合征/肿瘤患者生存结局的影响:考虑基线临床-分子风险和移植状态的国际骨髓增生异常综合征联盟(icMDS)分析
err2026-08-28
err0
PREAI
errBenjamin Rolles; Jan Philipp Bewersdorf; Tariq Kewan; Ondrej Blaha; Jessica M. Stempel; Luca Lanino; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Shougat Barua; Namrata Sonia Chandhok; Constantine Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Hayley Hawkins; Somedeb Ball; Justin Grenet; Parisa Abedi; Shai Shimony; R. Coleman Lindsley; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vasiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan; Maximilian Stahl
err分享
err收藏
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)多组学验证骨髓增生异常综合征(MDS)分子分类的临床相关性
err2026-07-28
err0
errOAAI
errGiulia Maggioni; Gabriele Todisco; Elisabetta Sauta; Luca Lanino; Somedeb Ball; Jan P. Bewersdorf; Tariq Kewan; Najla H. Al Ali; Pierre Fenaux; Uwe Platzbecker; Valeria Santini; Zhuoer Xie; Andrew M. Brunner; Andrew T. Kuykendall; John M. Bennett; Rena Buckstein; Rafael Bejar; Hetty E. Carraway; Amy E. DeZern; Elizabeth A. Griffiths; Stephanie Halene; Robert P. Hasserjian; Alan F. List; Sanam Loghavi; Olatoyosi Odenike; Eric Padron; Mrinal M. Patnaik; Gail J. Roboz; Maximilian Stahl; Mikkael A. Sekeres; David P. Steensma; Michael R. Savona; Justin Taylor; Mina L. Xu; David A. Sallman; Stephen D. Nimer; Christopher S. Hourigan; Andrew H. Wei; Alessia Campagna; Marta Ubezio; Elena Riva; Denise Ventura; Nicole Pinocchio; Matteo Zampini; Alessandro Buizza; Antonio Russo; Francesco Pesce; Saverio D'Amico; Gianluca Asti; Mattia Delleani; Erica Travaglino; Cristina A. Tentori; Ivan Ferrari; Alessandra Crespi; Giulia Figini; Maria Di Matteo; Matteo Brindisi; Nicla Manes; Chiara Milanesi; Laura Crisafulli; Francesca Ficara; Gastone Castellani; Uma M. Borate; Fabio Efficace; Steven D. Gore; Tae K. Kim; Maria Diez-Campelo; Arjan A. van de Loosdrecht; Navel Daver; Maria Rozman; Alberto Orfao; Sa A. Wang; Kathryn Foucar; Marcelo Iastrebner; Phillip Scheinberg; Yasushi Miyazaki; Yazan F. Madanat; Aref Al-Kali; Moshe Mittelmann; Thomas Cluzeau; Lionel Ades; Ulrich Germing; Guillermo Garcia-Manero; Shahram Kordasti; Torsten Haferlach; Amer M. Zeidan; Rami S. Komrokji; Matteo G. Della Porta; An international study on behalf of GenoMed4all, Synthema, and icMDS consortia
err分享
err收藏
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database高风险骨髓增生异常综合征/新生物患者接受去甲基化药物+维奈克拉治疗后的结局分析——国际骨髓增生异常综合征(icMDS)VALIDATE数据库分析
err2026-06-29
err0
errOAAI
errJan Philipp Bewersdorf; Tariq Kewan; Luca Lanino; Wei Wei; Tulika Rudra Gupta; Jessica M. Stempel; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Hayley Hawkins; Namrata Sonia Chandhok; Constantine N. Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Benjamin Rolles; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Somedeb Ball; Justin Grenet; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Jaclynn Campos; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vassiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Maximilian Stahl; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan
err分享
err收藏
Hematologic Responses Achieved with Luspatercept in Higher-Risk Myelodysplastic Syndromes使用卢斯帕特cept在高风险骨髓增生异常综合征中达到的血液学反应
err2026-06-08
err0
errOAAI
errDaniel Leonard; David A. Sallman; Kelly Pugh; Christopher Bell; Najila H. Al Ali; Uma Borate; Rami S. Komrokji; Andrew M. Brunner
err分享
err收藏
Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes治疗相关细胞减少症与低危骨髓增生异常综合征患者对imetelstat临床反应之间的关联
err2026-04-07
err0
errOAAI
errAmer M. Zeidan; Valeria Santini; María Díez-Campelo; Michael R. Savona; Mikkael A. Sekeres; Yazan F. Madanat; Pierre Fenaux; Azra Raza; Moshe Mittelman; Sylvain Thépot; Rena Buckstein; Ulrich Germing; David Valcárcel; Anna Jonášová; Sheetal Shah; Qi Xia; Libo Sun; Shyamala Navada; Tymara Berry; Uwe Platzbecker; Rami S. Komrokji
err分享
err收藏
Exposure to Agent Orange and Association with Myelodysplastic Syndromes暴露于橙剂及其与骨髓增生异常综合征的关联
err2026-03-02
err0
errOAAI
errMikkael A. Sekeres; Amy E. DeZern; Michael Otterstatter; Eric Padron; Tareq Al Baghdadi; James M. Foran; Rami S. Komrokji; Gregory A. Abel; Wael Saber; Steven D. Gore; Cecilia Lee; Rafael Bejar; Jane J. Liu; H. Joachim Deeg; Seth Sherman; R. Coleman Lindsley; Matthew J. Walter; Nancy Gillis
err分享
err收藏
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study《MDS自然病史研究中定义MDS及前体髓系疾病进展的一种新方法》
err2026-02-13
err0
errOAAI
errAmy E. DeZern; Nancy Gillis; Michael Otterstatter; Gregory Abel; Eric Padron; Jh Deeg; Tareq Al Baghdadi; Jane Liu; Zhuoer Xie; Ling Zhang; Lynn Moscinski; Steven Kroft; Alexandra Harrington; James Foran; Rami Komrokji; Daniel Starczynowski; Steven Gore; Wael Saber; Rafael Bejar; R. C. Lindsley
err分享
err收藏
Impact of Mutational Landscape and Burden on RBC Transfusion Response in Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the COMMANDS Study
err2026-01-19
err0
errOAAI
errRami S. Komrokji; Sheida Hayati; Manuel Ugidos; Guillermo Garcia-Manero; Matteo Giovanni Della Porta; Amer M. Zeidan; Valeria Santini; Uwe Platzbecker; Anita K. Gandhi; Rajasekhar N. V. S. Suragani
err分享
err收藏
Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat接受伊美替拉stat治疗低风险骨髓增生异常新生物患者的克隆性负荷调节
errLeukemia
IF13.4
err2026-01-12
err0
errOAAI
errValeria Santini; Amer M. Zeidan; Koen Van Eygen; Pierre Fenaux; Ulrich Germing; Yazan F. Madanat; Azra Raza; Michael R. Savona; Mikkael A. Sekeres; Sylvain Thépot; Marco G. Raddi; Thomas Boyer; Libo Sun; Ying Wan; Tymara Berry; Qi Xia; Fei Huang; Souria Dougherty; Shyamala Navada; Faye Feller; Rami S. Komrokji; Uwe Platzbecker
err分享
err收藏
Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS前期疗法对依赖输血、ESA复发或难治/不适用LR-MDS患者中imetelstat临床活性的影响
err2025-12-31
err0
errOAAI
errRami S. Komrokji; Valeria Santini; Amer M. Zeidan; Mikkael A. Sekeres; Pierre Fenaux; Azra Raza; Moshe Mittelman; Sylvain Thépot; Rena Buckstein; Ulrich Germing; Yazan F. Madanat; María Díez-Campelo; David Valcárcel; Anna Jonášová; Souria Dougherty; Sheetal Shah; Qi Xia; Libo Sun; Shyamala Navada; Faye Feller; Michael R. Savona; Uwe Platzbecker
err分享
err收藏
Post-transplant MRD Monitoring by TP53 Duplex Sequencing with APR-246 + Azacitidine Maintenance Predicts Outcomes移植后微小残留病(MRD)通过TP53双测序结合APR-246 + 去氧氟尿苷维持治疗预测预后
err2025-11-27
err0
errOAAI
errDavid A. Sallman; Amy F. McLemore; Rami Komrokji; Hany Elmariah; Andrew T. Kuykendall; Nelli Bejanyan; Onyee Chan; Rawan Faramand; Joseph Pidala; Sean J. Yoder; Lia Perez; Taiga Nishihori; Eric Padron; Hugo Fernandez; Jeffrey E. Lancet; Asmita Mishra
err分享
err收藏
Clinical outcomes and safety in patients with lower-risk myelodysplastic syndromes treated with imetelstat: Substudy of the phase 3 IMerge trial低危骨髓增生异常综合征患者接受伊米替列stat治疗后的临床疗效与安全性:IMerge三期试验的子研究
err2025-11-01
err0
errOAAI
errKomrokji, Rami S.; Santini, Valeria; Platzbecker, Uwe; Van Eygen, Koen; Diez-campelo, Maria; De Paz, Raquel; Santillana, Guillermo Sanz; Thepot, Sylvain; Kazmierczak, Maciej; Oliva, Esther Natalie; Sekeres, Mikkael A.; Fenaux, Pierre; Madanat, Yazan F.; Savona, Michael R.; Riggs, Jennifer; Shah, Sheetal; Lennox, Ashley L.; Xia, Qi; Sun, Libo; Berry, Tymara; Zeidan, Amer M.
err分享
err收藏
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms国际骨髓增生异常综合征/骨髓肿瘤工作组关于骨髓报告标准化的共识
err2025-10-01
err0
errOAAI
errGisriel, Savanah D.; Aakash, Fnu; Bennett, John M.; Hasserjian, Robert P.; Loghavi, Sanam; Dezern, Amy E.; Santini, Valeria; Savona, Michael R.; Brunner, Andrew M.; Buckstein, Rena; Wei, Andrew H.; Della Porta, Matteo G.; Komrokji, Rami S.; Borate, Uma M.; Sekeres, Mikkael A.; Platzbecker, Uwe; Fenaux, Pierre; Roboz, Gail J.; van de Loosdrecht, Arjan; Zeidan, Amer M.; Xu, Mina L.
err分享
err收藏
IMPACT OF PRIOR TREATMENTS ON THE CLINICAL ACTIVITY OF IMETELSTAT IN PATIENTS WITH TRANFUSION-DEPENDENT (TD), ERYTHROPOIESIS-STIMULATING AGENT (ESA) RELAPSED/REFRACTORY/INELIGIBLE LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS)既往治疗对输血依赖性(TD)、促红细胞生成剂(ESA)复发/难治/不适用低危骨髓增生异常综合征(LR-MDS)患者中imetelstat临床活性的影响
err2025-09-01
err0
errOAAI
errPlatzbecker, Uwe; Santini, Valeria; Zeidan, Amer; Sekeres, Mikkael; Fenaux, Pierre; Raza, Azra; Mittelman, Moshe; Thepot, Sylvain; Buckstein, Rena; Germing, Ulrich; Madanat, Yazan; Diez-Campelo, Maria; Ferreiras, David Valcarcel; Jonasova, Anna; Dougherty, Souria; Shah, Sheetal; Xia, Qi; Sun, Libo; Navada, Shyamala; Savona, Michael; Komrokji, Rami
err分享
err收藏
A COMPARISON OF PROGNOSTIC VARIABLES AND CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED AND 4738 WITH PRIMARY MDS INCLUDING THE INFLUENCE OF TREATMENT IN MDS-PHASE比较治疗相关和原发性MDS的1590例与4738例患者预后变量和细胞遗传学异常的比较,包括MDS阶段治疗的影响
err2025-09-01
err0
PREAI
errKuendgen, Andrea; Nomdedeu, Meritxell; Tuechler, Heinz; Garcia-Manero, Guillermo; Komrokji, Rami; Sekeres, Mikkael; Della Porta, Matteo; Malcovati, Luca; van de Loosdrecht, Arjan; Dezern, Amy; Roboz, Gail; Blum, Sabine; Valent, Peter; Giagounidis, Aristoteles; Platzbecker, Uwe; Lubbert, Michael; Dohner, Hartmut; Ganster, Christina; Strupp, Corinna; Hildebrandt, Barbara; Voso, Maria Teresa; Xicoy, Blanca; Calvete, Oriol; Calvo, Xavier; Arenillas, Leonor; Mestre, Julia; Ferreiras, David Valcarcel; Diez-Campelo, Maria; Diaz-Beya, Marina; Dolors, Costa; Diez-Cedena, Maria Teresa; Jordi, Esteve; Such, Esperanza; Grau, Javier; Oiartzabal, Itziar; Lopez-Pavia, Maria; Martinez-De-Sola, Montserrat; Nomdedeu, Benet; Sanz, Guillermo; Dietrich, Sascha; Greenberg, Peter; Germing, Ulrich; Sole, Francesc; Haase, Detlef
err分享
err收藏
AN ENSEMBLE AI MODEL FOR THE DIAGNOSIS MYELODYSPLASTIC SYNDROMES USING COMBINED BONE MARROW ASPIRATE AND BIOPSY SLIDES一种用于结合骨髓穿刺和活检涂片诊断骨髓增生异常综合征的集成AI模型
err2025-09-01
err0
errOAAI
errDave, Palak; Rai, Jordan; Zhang, Ling; Hussaini, Mohammad; Walker, Mary Ellen; Gillis, Nancy; Sekeres, Mikkael; Dezern, Amy; Padron, Eric; Komrokji, Rami; El Naqa, Issam
err分享
err收藏
Hypomethylating Agent and Venetoclax Combination Is a Safe and Effective Alternative to Intensive Chemotherapy in Older (≥ 70 Years) Patients With Newly Diagnosed Favorable Risk Acute Myeloid Leukemia去甲基化药物与Venetoclax联合方案是老年(≥70岁)新诊断低危急性髓系白血病患者接受强化化疗的安全有效替代方案。
err2025-08-07
err0
PREAI
errSomedeb Ball; Akriti G. Jain; Najla Al Ali; Luis E. Aguirre; Jan Philipp Bewersdorf; Andrew Kent; Ameera Rose; Alexander Hayden; Alexa Siddon; Jill Lykon; Ellen Madarang; David M. Swoboda; Eric Padron; Kendra Sweet; David A. Sallman; Jeffrey Lancet; Hetty E. Carraway; Justin Watts; Amer Zeidan; Daniel A. Pollyea; Rami S. Komrokji
err分享
err收藏
XPO1 Drives Resistance to Eprenetapopt and Azacitidine and Can Be Targeted in TP53 Mutated Myeloid MalignanciesXPO1驱动对Eprenetapopt和Azacitidine的抵抗,并且可以在TP53突变的髓系恶性疾病中作为靶点
errBlood
IF23.1
err2025-08-05
err0
PREAI
errTraci L. Kruer; Ariel Quintana; Hannah Newman; Meghan Ferrall-Fairbanks; Ling Zhang; Amy McLemore; Surendra Neupane; Qin Yang; Nana Adjoa Ben-Crentsil; Maria E. Balasis; Christopher Letson; Rami Komrokji; Sana Chaudhry; Tulasigeri M. Totiger; Joshua Traina; Maria E. Figueroa; Christopher B. Ryder; Thomas Cluzeau; Justin Taylor; David A. Sallman; Eric Padron
err分享
err收藏
err分享
err收藏